BioCentury
BioCentury This Week
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Besuch unbedingt die Website des Podcasts und unterstütze die Macher: www.biocentury.com
Wo hören?
Podcasts in der App Replaio Radio Bald verfügbarPodcasts kommen bald in die App. Installiere sie jetzt und erlebe als Erster einen ganz neuen Blick auf Podcasts
Kostenlos installieren
Android fast 10 Mio. Downloads · Bewertung 4,8
iOS bald
Folgen
Ep 76 Pt. 2 - Standards of Evidence for Accelerated Approval 30.08.2021 14:52
Reach us by sending a text
Ep 76 Pt. 1 - Accelerated Approval's Big Picture 30.08.2021 22:09
Reach us by sending a text
Ep. 75 - Back to School Preview, plus Pfizer Eats Trillium 24.08.2021 22:59
Reach us by sending a text
Ep. 74 - Vertex's Road Map & Innovation in MS 16.08.2021 13:31
Reach us by sending a text
Ep. 73 - Next Up in COVID with Otello Stampacchia and Umer Raffat 13.08.2021 19:05
Reach us by sending a text
Ep. 72 - Modality Matters: M&A Heats Up, Galbraith Maps AZ's BD 09.08.2021 18:27
Reach us by sending a text
Ep. 71 - Lessons from China’s Market Turmoil, Plus Distillery on Tap 03.08.2021 27:03
Reach us by sending a text
Ep. 70 - Prepping for China’s IP law with Jones Day’s Tony Chen 29.07.2021 17:19
Reach us by sending a text
Ep. 69 - Allaying Aduhelm Concerns, Plus Master Protocols, Arvinas-Pfizer 27.07.2021 14:30
Reach us by sending a text
Ep. 68 - Drug Pricing Pressure, Plus European Deal Trends 20.07.2021 26:19
Reach us by sending a text
Ep. 67 - Aduhelm: a Tangled Plot; Plus, INTREPID Pandemic Planning 13.07.2021 32:15
Reach us by sending a text
Ep. 66 - Biotechs hit 3Q with Coolers Full of Cash; plus Distillery on Tap 06.07.2021 21:36
Reach us by sending a text
Ep. 65 - Optimism for Intellia's CRISPR Breakthrough, Concerns about Aduhelm 29.06.2021 22:58
Reach us by sending a text
Ep. 64 - Amyloid Analysis: Stress Testing FDA's Logic on Surrogate Endpoint 24.06.2021 18:43
Reach us by sending a text
Ep. 63 - Woodcock, Noubar and Genmab’s dealmaking: A BioCentury Podcast 21.06.2021 24:46
Reach us by sending a text
Ep. 62 - Reflecting on the Implications of Aduhelm's Approval: A BioCentury Podcast 14.06.2021 18:32
Reach us by sending a text
Ep. 61 - Dissecting FDA's Aducanumab Decision 08.06.2021 25:24
Reach us by sending a text
Ep. 60 - D-Day for Aducanumab: What's at stake 02.06.2021 15:10
Reach us by sending a text
Ep. 59 - KRAS to the Future; plus ARPA-H & EGFR 02.06.2021 23:45
Reach us by sending a text
Ep. 58 - LAG3 Before You Leap; plus BEE21, G20 Highlights 24.05.2021 24:46
Reach us by sending a text
Ep. 57 - Financing Scandinavia; plus IP Waivers, Long Covid & AAV Pays 10.05.2021 28:06
Reach us by sending a text
Ep. 56 - FDA’s ODAC Bind; plus NK Cell Engagers and Company Creation in Europe 04.05.2021 20:37
Reach us by sending a text
Ep. 55 - German Plays Deliver on Data, plus Accelerated Approval on Trial 27.04.2021 19:06
Reach us by sending a text
Ep. 54 - Patient Groups’ Pandemic Pain; plus Voters’ Rights and Synthetic Lethality 20.04.2021 25:51
Reach us by sending a text
Ep. 53 - Competence & Continuity at CDER; plus BIO 3.0, AACR and 2Q Preview 13.04.2021 23:45
Reach us by sending a text
Ähnliche Podcasts
Höre den Podcast BioCentury This Week in Replaio
Radio und Podcasts in einer App - kostenlos und ohne Anmeldung. Installiere sie noch heute und verpasse den Start nicht
Replaio ist kein Herausgeber von Podcasts; die Namen der Sendungen, Cover und Audioinhalte gehören ihren Autoren und werden über öffentliche RSS-Feeds verbreitet
